Open AccessLarge-scale screening of human sera with cytomegalovirus recombinant antigens
Author(s) -
M.P. Landini,
Ming Guan,
Gerhard Jahn,
Werner Lindenmaier,
Michael Mach,
Alessandro Ripalti,
Antje Necker,
Tiziana Lazzarotto,
Bodo Plachter
Publication year - 1990
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.28.6.1375-1379.1990
Subject(s) - recombinant dna , virology , human cytomegalovirus , antigen , epitope , serology , cytomegalovirus , antibody , biology , fusion protein , blot , betaherpesvirinae , herpesviridae , immunology , microbiology and biotechnology , virus , viral disease , biochemistry , gene
One of the major problems regarding cytomegalovirus (CMV) serodiagnosis is the use of poorly defined viral antigens. Individual CMV proteins expressed via recombinant DNA procedures are a promising approach to solving this problem. In this work, 10 different fusion proteins containing antigenic epitopes of the major CMV structural proteins of 150, 71, 65, 38, and 28 kilodaltons and of the nonstructural protein of 52 kilodaltons were subjected to Western (immuno-) blotting to assay their reactivities with immunoglobulins G and M in 395 CMV-seropositive and 100 CMV-seronegative unselected human serum samples. As a whole, the results obtained indicate that CMV can be replaced by recombinant viral proteins in the serological evaluation of anti-CMV antibodies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom